The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Molecular pathology of schizophrenia: more than one disease process?
Open accessAbstract
We have developed a generally applicable method based on CRISPR/Cas9-targeted ultra-long read sequencing (CTLR-Seq) to completely and haplotype-specifically resolve, at base-pair resolution, large, complex, and highly repetitive genomic regions that had been previously impenetrable to next-generation sequencing analysis such as large segmental duplication (SegDup) regions and their associated genome rearrangements that stretch hundreds of kilobases. Our method combines in vitro Cas9-mediated cutting of the genome and pulse-field gel electrophoresis to haplotype-specifically isolate intact large (200-550 kb) target regions that encompass previously unresolvable genomic sequences. These target fragments are then sequenced (amplification-free) to produce ultra-long reads at up to 40x on-target coverage using Oxford nanopore technology, allowing for the complete assembly of the complex genomic regions of interest at single base-pair resolution. We applied CTLR-Seq to resolve the exact sequence of SegDup rearrangements that constitute the boundary regions of the 22q11.2 deletion CNV and of the 16p11.2 deletion and duplication CNVs. These CNVs are among the strongest known risk factors for schizophrenia and autism. We then perform de novo assembly to resolve, for the first time, at single base-pair resolution, the sequence rearrangements of the 22q11.2 and 16p11.2 CNVs, mapping out exactly the genes and non-coding regions that are affected by the CNV for different carriers.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs
Creese, I., Burt, D. R., & Snyder, S. H. (1976) · Science · doi:10.1126/science.3854 · Cited by 2,220
Carlsson, A., & Lindqvist, M. (1963) · Acta Pharmacologica et Toxicologica · doi:10.1111/j.1600-0773.1963.tb01730.x · Cited by 2,148
Dalgleish, T. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1432 · Cited by 1,849
Antipsychotic drug doses and neuroleptic/dopamine receptors
SEEMAN, P., LEE, T., CHAU-WONG, M., & WONG, K. (1976) · Nature · doi:10.1038/261717a0 · Cited by 1,622
Stereotyped activities produced by amphetamine in several animal species and man
Randrup, A., & Munkvad, I. (1967) · Psychopharmacologia · doi:10.1007/bf00404607 · Cited by 613
A BIOCHEMICAL AND PHARMACOLOGICAL SUGGESTION ABOUT CERTAIN MENTAL DISORDERS
Woolley, D. W., & Shaw, E. (1954) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.40.4.228 · Cited by 602
Lateral Cerebral Ventricular Enlargement in Chronic Schizophrenia
Weinberger, D. R. (1979) · Archives of General Psychiatry · doi:10.1001/archpsyc.1979.01780070013001 · Cited by 570
INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA
Owen, F., Crow, T. J., Poulter, M., Cross, A. J., Longden, A., & Riley, G. J. (1978) · The Lancet · doi:10.1016/s0140-6736(78)91740-3 · Cited by 518
Self-citationStein, L., & Wise, C. D. (1971) · Science · doi:10.1126/science.171.3975.1032 · Cited by 477
MECHANISM OF THE ANTIPSYCHOTIC EFFECT IN THE TREATMENT OF ACUTE SCHIZOPHRENIA
Johnstone, E., Frith, C. D., Crow, T. J., Carney, M. W. P., & Price, J. S. (1978) · The Lancet · doi:10.1016/s0140-6736(78)90193-9 · Cited by 458
Self-citationAnti-muscarinic properties of neuroleptics and drug-induced Parkinsonism
MILLER, R. J., & HILEY, C. R. (1974) · Nature · doi:10.1038/248596a0 · Cited by 381
Reduced Monoamine Oxidase Activity in Blood Platelets from Schizophrenic Patients
MURPHY, D. L., & WYATT, R. J. (1972) · Nature · doi:10.1038/238225a0 · Cited by 360
Binding of 3H-neuroleptics and 3H-apomorphine in schizophrenic brains
LEE, T., SEEMAN, P., TOURTELLOTTE, W. W., FARLEY, I. J., & HORNYKEIWICZ, O. (1978) · Nature · doi:10.1038/274897a0 · Cited by 351
Muller, P., & Seeman, P. (1977) · Life Sciences · doi:10.1016/0024-3205(77)90155-2 · Cited by 300
AMPHETAMINE PSYCHOSIS: I. DESCRIPTION OF THE INDIVIDUALS AND PROCESS
ELLINWOOD, E. H. (1967) · The Journal of NERVOUS and MENTAL DISEASE · doi:10.1097/00005053-196704000-00005 · Cited by 285
Bartosik, V. (2008) · Encyclopedia of Special Education · doi:10.1002/9780470373699.speced0124 · Cited by 280
The dementia of dementia praecox
Johnstone, E. C., Crow, T. J., Frith, C. D., Stevens, M., Kreel, L., & Husband, J. (1978) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1978.tb06899.x · Cited by 270
Self-citationCentral Dopamine Turnover in Schizophrenic Syndromes
Bowers, M. B. (1974) · Archives of General Psychiatry · doi:10.1001/archpsyc.1974.01760130034005 · Cited by 270
MILLER, R. J., HORN, A. S., & IVERSEN, L. L. (1974) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13988-6 · Cited by 256
Pneumoencephalographic studies in mental disease.
HAUG, J. O. (1962) · PubMed · Cited by 244
Andén, N.-E. (1972) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1972.tb08912.x · Cited by 236
Monoamine Mechanisms in Chronic Schizophrenia: Post-Mortem Neurochemical Findings
Crow, T. J., Baker, H. F., Cross, A. J., Joseph, M. H., Lofthouse, R., Longden, A., Owen, F., Riley, G. J., Glover, V., & Killpack, W. S. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.3.249 · Cited by 213
Self-citationIntracranial self-stimulation with electrodes in the region of the locus coeruleus
Crow, T. J., Spear, P. J., & Arbuthnott, G. W. (1972) · Brain Research · doi:10.1016/0006-8993(72)90735-4 · Cited by 211
Self-citationCerebrospinal Fluid Amine Metabolites in Acute Schizophrenia
Post, R. M. (1975) · Archives of General Psychiatry · doi:10.1001/archpsyc.1975.01760260127011 · Cited by 203
POSSIBLE VIRUS IN SCHIZOPHRENIA AND SOME NEUROLOGICAL DISORDERS
Tyrrell, D. A. J., Parry, R. P., Crow, T. J., Johnstone, E. C., & Ferrier, I. N. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91261-3 · Cited by 127
Self-citationCrow, T. J., Johnstone, E. C., Deakin, J. F. W., & Longden, A. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91807-9 · Cited by 97
Self-citationHyporesponsivity of Chronic Schizophrenic Patients to Dextroamphetamine
Kornetsky, C. H. (1976) · Archives of General Psychiatry · doi:10.1001/archpsyc.1976.01770120029002 · Cited by 90
The nucleus accumbens–possible site of antipsychotic action of neuroleptic drugs?
Crow, T. J., Deakin, J. F. W., & Longden, A. (1977) · Psychological Medicine · doi:10.1017/s0033291700029287 · Cited by 86
Self-citationCross, A. J., Crow, T. J., Killpack, W. S., Longden, A., Owen, F., & Riley, G. J. (1978) · Psychopharmacology · doi:10.1007/bf00427744 · Cited by 84
Self-citationJoseph, M. H., Baker, H. F., Crow, T. J., Riley, G. J., & Risby, D. (1979) · Psychopharmacology · doi:10.1007/bf00431959 · Cited by 80
Self-citationAge Disorientation in Chronic Schizophrenia: The Nature of the Cognitive Deficit
Crow, T. J., & Stevens, M. (1978) · The British Journal of Psychiatry · doi:10.1192/bjp.133.2.137 · Cited by 69
Self-citationCotes, P. M., Crow, T. J., Johnstone, E. C., Bartlett, W. A., & Bourne, R. C. (1978) · Psychological Medicine · doi:10.1017/s0033291700018869 · Cited by 68
Self-citationCrow, T. J., & Mitchell, W. S. (1975) · The British Journal of Psychiatry · doi:10.1192/bjp.126.4.360 · Cited by 65
Self-citationNeurotransmitter receptors in brain in schizophrenia
Owen, F., Cross, A. J., Crow, T. J., Lofthouse, R., & Poulter, M. (1981) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1981.tb02455.x · Cited by 62
Self-citationViral causes of psychiatric disease
Crow, T. J. (1978) · Postgraduate Medical Journal · doi:10.1136/pgmj.54.637.763 · Cited by 42
Self-citationCrow, T. J., & Gillbe, C. E. (1974) · Journal of Psychiatric Research · doi:10.1016/0022-3956(74)90088-0 · Cited by 25
Self-citationAmphetamine Psychosis: I. Description of the Individuals and Process
Ellinwood, E. H. (1969) · Journal of Psychedelic Drugs · doi:10.1080/02791072.1969.10524414 · Cited by 20
Cited by
The Positive and Negative Syndrome Scale (PANSS) for schizophrenia.
Kay, S. R., Fiszbein, A., & Opler, L. A. (1987) · Schizophrenia Bulletin · doi:10.1093/schbul/13.2.261 · Cited by 21,378
Implications of Normal Brain Development for the Pathogenesis of Schizophrenia
Weinberger, D. R. (1987) · Archives of General Psychiatry · doi:10.1001/archpsyc.1987.01800190080012 · Cited by 3,724
The Self-Medication Hypothesis of Substance Use Disorders: A Reconsideration and Recent Applications
Khantzian, E. J. (1997) · Harvard Review of Psychiatry · doi:10.3109/10673229709030550 · Cited by 3,242
Negative Symptoms in Schizophrenia: Definition and Reliability
Andreasen, N. C. (1982) · Archives of General Psychiatry · doi:10.1001/archpsyc.1982.04290070020005 · Cited by 2,247
A neuropsychological theory of positive affect and its influence on cognition.
Ashby, F. G., Isen, A. M., & Turken, A. U. (1999) · Psychological Review · doi:10.1037/0033-295x.106.3.529 · Cited by 2,270
Metadata
- Authors
- Crow, T. J.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 1980-01-12
- Volume
- 280
- Issue
- 6207
- Pages
- 66-68
- ISSN
- 0007-1447 (ISSN-L)
- 1468-5833
- OpenAlex
- W1970814820
- Cited by
- 1,856
- References
- 37
- FWCI
- 26.13
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.